scite — Funding & Company Data

scite's funding history is atypical for a SaaS startup, relying on prestigious Small Business Innovation Research (SBIR) grants rather than traditional venture capital. This path signals a strong focus on deep R&D and validation from federal scientific bodies, which valued its core mission of making science more reliable. The grants from the National Science Foundation ($224.6K) and the National Institute on Drug Abuse ($1.5M) underscore the technology's perceived importance and potential impact within the scientific community. This non-dilutive funding allowed the team to focus on product development and technological validation without the immediate pressures of commercialization often imposed by VCs.

The culmination of this early work was the acquisition by Research Solutions, a publicly traded company, in late 2023. This was a strategic exit for the founders and a significant event for users. The acquisition provides scite with the resources and stability of a larger, established company, effectively eliminating the runway concerns typical of a startup. Being part of the Research Solutions ecosystem, which includes the Article Galaxy platform, provides significant cross-selling opportunities and integrates scite into a broader research workflow, enhancing its value proposition. The acquisition price of ~$20.9M reflects a solid outcome for a company that had raised less than $2M in grant funding.